Priority medicines for Europe and the world
暂无分享,去创建一个
[1] N. Daniels,et al. Limits to health care: fair procedures, democratic deliberation, and the legitimacy problem for insurers. , 1997, Philosophy & public affairs.
[2] S. Preskorn,et al. Clinically Relevant Pharmacology of Selective Serotonin Reuptake Inhibitors , 1997, Clinical pharmacokinetics.
[3] D. Calfee,et al. Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] N. Terry,et al. The Emergence of National Electronic Health Record Architectures in the United States and Australia: Models, Costs, and Questions , 2005, Journal of medical Internet research.
[5] J. Ito,et al. Drug Delivery to the Cochlea Using PLGA Nanoparticles , 2005, The Laryngoscope.
[6] Sonja Marjanovic,et al. Engaging biotechnology companies in the development of innovative solutions for diseases of poverty , 2004, Nature Reviews Drug Discovery.
[7] I. Blackburn,et al. A meta-analysis of the effects of cognitive therapy in depressed patients. , 1998, Journal of affective disorders.
[8] N. Black,et al. Patient determinants of mental health interventions in primary care. , 2000, The British journal of general practice : the journal of the Royal College of General Practitioners.
[9] D. Cullum,et al. Occupational low back pain and intervertebral disc degeneration: epidemiology, imaging, and pathology. , 1994, The Clinical journal of pain.
[10] D. Jolley,et al. Cost benefits of a medically supervised day treatment program for patients with Alzheimer's disease and other forms of dementia , 1989 .
[11] J. Eyles,et al. Deliberations about deliberative methods: issues in the design and evaluation of public participation processes. , 2003, Social science & medicine.
[12] K. Namkoong,et al. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study. , 2003, Alcohol and alcoholism.
[13] P. Tugwell,et al. Electromagnetic fields for the treatment of osteoarthritis. , 2002, The Cochrane database of systematic reviews.
[14] R S Koff,et al. Extrahepatic Manifestations of Hepatitis C and the Association with Alcoholic Liver Disease , 1995, Seminars in liver disease.
[15] A. Williams,et al. Calculating the global burden of disease: time for a strategic reappraisal? , 1999, Health economics.
[16] R. Pauwels,et al. GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION , 1996 .
[17] J. Boote,et al. What does it mean to involve consumers successfully in NHS research? A consensus study , 2004, Health expectations : an international journal of public participation in health care and health policy.
[18] Jill Chopyak,et al. Public participation in science and technology decision making: trends for the future , 2002 .
[19] Z. Bhutta,et al. How many child deaths can we prevent this year? , 2003, The Lancet.
[20] Jeremiah Stamler,et al. Blood Pressure, Systolic and Diastolic, and Cardiovascular Risks: US Population Data , 1993 .
[21] M. Thase,et al. Fluoxetine in depressed alcoholics. A double-blind, placebo-controlled trial. , 1997, Archives of general psychiatry.
[22] S. Wessely,et al. A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. , 2002, Health technology assessment.
[23] J. Heyse,et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. , 2006, The New England journal of medicine.
[24] J. Powles,et al. Fruit and vegetables, and cardiovascular disease: a review. , 1997, International journal of epidemiology.
[25] F. Shenfield. Ethical issues in the genetic aspects of haemophilia , 2002, Haemophilia : the official journal of the World Federation of Hemophilia.
[26] John Pickup,et al. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. , 2002, Diabetes care.
[27] Paul Dieppe,et al. Relation between agendas of the research community and the research consumer , 2000, The Lancet.
[28] E. Damsgaard,et al. Drug therapy in the elderly: what doctors believe and patients actually do. , 2001, British journal of clinical pharmacology.
[29] H. Chakraborty,et al. Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial , 2006, The Lancet.
[30] M. Selby-Harrington,et al. Identification and treatment of children's mental health problems by primary care providers: a critical review of research. , 1996, Archives of psychiatric nursing.
[31] M. Luster,et al. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat , 1997, Hepatology.
[32] H. Eriksen,et al. Does Early Intervention With a Light Mobilization Program Reduce Long-Term Sick Leave for Low Back Pain? , 2000, Spine.
[33] Chiara Ruini,et al. Treatment of Recurrent Depression , 2003, CNS drugs.
[34] M. Hotopf,et al. Depression in advanced disease: a systematic review - Part 1. Prevalence and case finding , 2002 .
[35] J. Bongaarts. United Nations Department of Economic and Social Affairs, Population Division World Mortality Report 2005 , 2006 .
[36] C Osmond,et al. Fetal and infant growth and impaired glucose tolerance at age 64. , 1991, BMJ.
[37] S. Yusuf,et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.
[38] Carol Barker,et al. Opening the debate on DALYs , 1996 .
[39] Stephen H. D. Jackson,et al. Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. , 2003, British journal of clinical pharmacology.
[40] S. Yusuf,et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study , 2004, The Lancet.
[41] J. Cox,et al. Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. , 2001, BMJ : British Medical Journal.
[42] G. '. Jong. Unlicensed and off-label drug use in children , 2002 .
[43] C. Horsfield,et al. Efficacy of the Combination Rifampin-Streptomycin in Preventing Growth of Mycobacterium ulcerans in Early Lesions of Buruli Ulcer in Humans , 2005, Antimicrobial Agents and Chemotherapy.
[44] M Tubiana,et al. Measuring progress against cancer in Europe: has the 15% decline targeted for 2000 come about? , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[45] N. Lapointe,et al. Dried blood spots collected on filter paper: an international resource for the diagnosis and genetic characterization of human immunodeficiency virus type-1. , 1996, Memorias do Instituto Oswaldo Cruz.
[46] M. Gracey. Child health in an urbanizing world , 2002, Acta paediatrica.
[47] Kay W Chang,et al. Prevention of Cisplatin Ototoxicity Using Transtympanic N-Acetylcysteine and Lactate , 2004, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[48] J. Boote,et al. Consumer involvement in health research: a review and research agenda. , 2002, Health policy.
[49] K. Alberti. Treating type 2 diabetes – today's targets, tomorrow's goals , 2001, Diabetes, obesity & metabolism.
[50] Elias Mossialos,et al. Affordably priced new drugs for poor populations: Approaches for a global solution. , 2001, The International journal of risk & safety in medicine.
[51] R Day,et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.
[52] B. Popkin,et al. Obesity and inequities in health in the developing world , 2004, International Journal of Obesity.
[53] J R Hodges,et al. The prevalence of frontotemporal dementia , 2002, Neurology.
[54] S. Anand,et al. Disability-adjusted life years: a critical review. , 1997, Journal of health economics.
[55] M. Pallansch,et al. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children , 1991, The Lancet.
[56] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[57] D. Kay,et al. Clinically diagnosed presenile dementia of the Alzheimer type in the Northern Health Region: ascertainment, prevalence, incidence and survival , 1993, Psychological Medicine.
[58] L. Manchikanti. Epidemiology of low back pain. , 2000, Pain physician.
[59] E. Vardas,et al. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual. , 1999, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[60] K. R. Chapman,et al. Epidemiology and costs of chronic obstructive pulmonary disease , 2006, European Respiratory Journal.
[61] B. Wilcken,et al. Screening newborns for inborn errors of metabolism by tandem mass spectrometry. , 2003, The New England journal of medicine.
[62] S. Deeks,et al. Treatment of antiretroviral-drug-resistant HIV-1 infection , 2003, The Lancet.
[63] M. Weinstein,et al. Long-term persistence in use of statin therapy in elderly patients. , 2002, JAMA.
[64] D. Elbourne,et al. The Bristol third stage trial: active versus physiological management of third stage of labour. , 1988, BMJ.
[65] Marc Fisher,et al. The Ischemic Penumbra: Identification, Evolution and Treatment Concepts , 2003, Cerebrovascular Diseases.
[66] Jean-Louis Martin,et al. Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction Final Report of the Lyon Diet Heart Study , 1999 .
[67] B. Reiss,et al. The prevalence of dementia as measured by the Cambridge Mental Disorders of the Elderly Examination , 1989, Acta psychiatrica Scandinavica.
[68] A Hofman,et al. The prevalence of dementia in Europe: a collaborative study of 1980-1990 findings. Eurodem Prevalence Research Group. , 1991, International journal of epidemiology.
[69] R. Segal,et al. A pharmacoeconomic analysis of IV H2-receptor antagonist use in 40 hospitals. , 1994, Hospital formulary.
[70] S. Patten,et al. Long-Term Medical Conditions and Major Depression: Strength of Association for Specific Conditions in the General Population , 2005, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[71] B. Davis,et al. ALLHAT: Setting the Record Straight , 2004, Annals of Internal Medicine.
[72] M. Moses,et al. Two decades of orphan product development , 2002, Nature Reviews Drug Discovery.
[73] R. Anton,et al. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. , 1999, The American journal of psychiatry.
[74] B. Greenwood. The epidemiology of malaria. , 1997, Annals of tropical medicine and parasitology.
[75] W. Hennink,et al. Shifting paradigms: biopharmaceuticals versus low molecular weight drugs. , 2003, International journal of pharmaceutics.
[76] D. Elbourne,et al. Active versus expectant management in third stage of labour (Cochrane Review) , 2002 .
[77] Suellen Miller,et al. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. , 2004, Journal of midwifery & women's health.
[78] M K Campbell,et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. , 2004, Health technology assessment.
[79] K. Lohr,et al. Discontinuation rates for selective serotonin reuptake inhibitors and other second-generation antidepressants in outpatients with major depressive disorder: a systematic review and meta-analysis , 2005, International clinical psychopharmacology.
[80] Stephane Jacobzone,et al. Pharmaceutical Policies in OECD Countries , 2000 .
[81] K. Wilson,et al. Antidepressants for depressed elderly. , 2006, The Cochrane database of systematic reviews.
[82] V. Entwistle,et al. Consumer involvement in decisions about what health-related research is funded. , 2004, Health policy.
[83] P. Morlat,et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. , 2005, Journal of hepatology.
[84] J. Neuberger,et al. Assessing priorities for allocation of donor liver grafts: survey of public and clinicians , 1998, BMJ.
[85] N. Bellamy,et al. Intraarticular corticosteroid for treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.
[86] Alan D. Lopez,et al. The utility of DALYs for public health policy and research: a reply. , 1997, Bulletin of the World Health Organization.
[87] J. Breman,et al. The intolerable burden of malaria: a new look at the numbers. , 2001, The American journal of tropical medicine and hygiene.
[88] Diederick E Grobbee,et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.
[89] M. Thase. Comparing the methods used to compare antidepressants. , 2002, Psychopharmacology bulletin.
[90] Helen Lapsley,et al. Utilising survey data to inform public policy: Comparison of the cost-effectiveness of treatment of ten mental disorders , 2004, British Journal of Psychiatry.
[91] R. Foy,et al. Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold , 1999, BMJ.
[92] Ronald C Kessler,et al. Effects of major depression on moment-in-time work performance. , 2004, The American journal of psychiatry.
[93] R. W. Hansen,et al. The price of innovation: new estimates of drug development costs. , 2003, Journal of health economics.
[94] A Ogunniyi,et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. , 2001, JAMA.
[95] J A Buckwalter,et al. Aging and degeneration of the human intervertebral disc. , 1995, Spine.
[96] M. Felisi,et al. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products , 2002, European Journal of Clinical Pharmacology.
[97] J. Jordan,et al. Comparison of 16S rRNA Gene PCR and BACTEC 9240 for Detection of Neonatal Bacteremia , 2000, Journal of Clinical Microbiology.
[98] Alastair Baker,et al. Crossing the Quality Chasm: A New Health System for the 21st Century , 2001, BMJ : British Medical Journal.
[99] Oscar L. Lopez,et al. Survival following dementia onset: Alzheimer's disease and vascular dementia , 2005, Journal of the Neurological Sciences.
[100] N. Sacktor. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. , 2002, Journal of neurovirology.
[101] G. Mooney,et al. "Communitarian claims" as an ethical basis for allocating health care resources. , 1998, Social science & medicine.
[102] D. Aarsland,et al. A systematic review of prevalence studies of dementia in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.
[103] M. Weinstein,et al. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. , 2005, Vaccine.
[104] E. Berndt,et al. The Clinical and Occupational Correlates of Work Productivity Loss Among Employed Patients With Depression , 2004, Journal of occupational and environmental medicine.
[105] H. An,et al. Prevention of disc degeneration with growth factors , 2006, European Spine Journal.
[106] T. Morata. Assessing occupational hearing loss: beyond noise exposures. , 1998, Scandinavian audiology. Supplementum.
[107] R. Nitsch,et al. Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. , 2003, Archives of neurology.
[108] R. Birrer. Depression and aging too often do mix. , 1998, Postgraduate medicine.
[109] H. Vuorela,et al. Treatment of Acute Low Back Pain With the COX-2–Selective Anti-Inflammatory Drug Nimesulide: Results of a Randomized, Double-Blind Comparative Trial Versus Ibuprofen , 2000, Spine.
[110] Xiao-Hua Zhou,et al. Cost-effectiveness of improving primary care treatment of late-life depression. , 2005, Archives of general psychiatry.
[111] J. Bensing,et al. Bridging the gap. The separate worlds of evidence-based medicine and patient-centered medicine. , 2000, Patient education and counseling.
[112] K. Wells,et al. Improving the care for depression in patients with comorbid medical illness. , 2002, The American journal of psychiatry.
[113] K Yaffe,et al. Midlife cardiovascular risk factors and risk of dementia in late life , 2005, Neurology.
[114] A. Svennerholm,et al. Double-blind, randomized, placebo controlled pilot study evaluating efficacy and reactogenicity of an oral ETEC B-subunit-inactivated whole cell vaccine against travelers' diarrhea (preliminary report). , 2006, Journal of travel medicine.
[115] J. Britton,et al. High-dose inhaled albuterol in severe chronic airflow limitation. , 1988, The American review of respiratory disease.
[116] E. Bonifacio,et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. , 1999, Diabetes.
[117] Jeffrey Jarvik,et al. Diagnostic Evaluation of Low Back Pain with Emphasis on Imaging , 2002, Annals of Internal Medicine.
[118] L S Honig,et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease , 2005, Neurology.
[119] S. T. Yoon,et al. Molecular therapy of the intervertebral disc. , 2005, European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society.
[120] A. Hofman,et al. Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.
[121] Abdullah Pandor,et al. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: a systematic review , 2004 .
[122] M. Rewers,et al. Comparison of the incidence of insulin-dependent diabetes mellitus in childhood among five Baltic populations during 1983-1988. , 1992, International journal of epidemiology.
[123] R. Ruben. Redefining the Survival of the Fittest: Communication Disorders in the 21st Century , 2000, The Laryngoscope.
[124] C. Dollery. Pharmacological basis for combination therapy of hypertension. , 1977 .
[125] J. Vioque,et al. Time spent watching television, sleep duration and obesity in adults living in Valencia, Spain , 2000, International Journal of Obesity.
[126] G. Hofmeyr,et al. Rectal misoprostol in the prevention of postpartum hemorrhage: a placebo-controlled trial. , 1998, American journal of obstetrics and gynecology.
[127] S. Cummings,et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.
[128] Bernadette Modell,et al. March of Dimes: global report on birth defects, the hidden toll of dying and disabled children. , 2005 .
[129] A. D. de Craen,et al. Analgesic efficacy and safety of paracetamol-codeine combinations versus paracetamol alone: a systematic review , 1996, BMJ.
[130] J. Samet. The health benefits of smoking cessation. , 1991, The Medical clinics of North America.
[131] B. Rounsaville,et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. , 1992, Archives of general psychiatry.
[132] D. Henry,et al. Comparing treatments , 1995, BMJ.
[133] A. Mattioli,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[134] E. Rönmark,et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). , 2002, Respiratory medicine.
[135] R Martorell,et al. Prevention of diarrhea and pneumonia by zinc supplementation in children in developing countries: pooled analysis of randomized controlled trials. Zinc Investigators' Collaborative Group. , 1999, The Journal of pediatrics.
[136] Ozgur Yorbik,et al. Clinical characteristics of depressive symptoms in children and adolescents with major depressive disorder. , 2004, The Journal of clinical psychiatry.
[137] N. Khaltaev,et al. Low back pain initiative , 1999 .
[138] K. Whetten-Goldstein,et al. Hospital pharmacy decisions, cost containment, and the use of cost-effectiveness analysis. , 1997, Social science & medicine.
[139] R. Stewart,et al. A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. , 2005, Archives of neurology.
[140] M. Donaldson,et al. Setting Priorities for Health Technology Assessment , 1992 .
[141] R. Cooke,et al. Antibiotic regimens for suspected early neonatal sepsis. , 2004, The Cochrane database of systematic reviews.
[142] Benedetto Vitiello,et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. , 2004, JAMA.
[143] J. Potash,et al. Effects of improved water supply and sanitation on ascariasis, diarrhoea, dracunculiasis, hookworm infection, schistosomiasis, and trachoma. , 1991, Bulletin of the World Health Organization.
[144] A. Rush,et al. ECT Remission Rates in Psychotic Versus Nonpsychotic Depressed Patients: A Report from CORE , 2001, The journal of ECT.
[145] J. Urquhart,et al. Controlled drug delivery: therapeutic and pharmacological aspects , 2000 .
[146] Peter Beresford,et al. User involvement in research: Exploring the challenges , 2003 .
[147] G. Livingston,et al. Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.
[148] Alan D. Lopez,et al. Regional patterns of disability-free life expectancy and disability-adjusted life expectancy: Global Burden of Disease Study , 1997, The Lancet.
[149] A. Tylee,et al. Managing depression in primary care , 2005, BMJ : British Medical Journal.
[150] S. Croft,et al. Leishmaniasis--current chemotherapy and recent advances in the search for novel drugs. , 2003, Trends in parasitology.
[151] D. Wood,et al. Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries , 2001, The Lancet.
[152] Brendan A. Larder,et al. Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates , 2002, Antimicrobial Agents and Chemotherapy.
[153] M. Makame. Childhood Diabetes, Insulin, and Africa , 1992 .
[154] P. Marty,et al. The biological diagnosis of leishmaniasis in HIV-infected patients , 2003, Annals of tropical medicine and parasitology.
[155] J. Lemons,et al. Volume of blood submitted for culture from neonates , 1986, Journal of clinical microbiology.
[156] M M Weissman,et al. Depressed adolescents grown up. , 1999, JAMA.
[157] H. Kraemer,et al. Are certain multicenter randomized clinical trial structures misleading clinical and policy decisions? , 2005, Contemporary clinical trials.
[158] B. Grant,et al. Epidemiology of Alcoholic Liver Disease , 1988, Seminars in liver disease.
[159] J Bousquet,et al. Chronic respiratory diseases in developing countries: the burden and strategies for prevention and management. , 2001, Bulletin of the World Health Organization.
[160] S. Faraone,et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. , 1996, American journal of medical genetics.
[161] D. Lovinger,et al. Cellular and behavioral neurobiology of alcohol: receptor-mediated neuronal processes. , 1995, Clinical neuroscience.
[162] S. Loft,et al. Increased susceptibility to liver disease in relation to alcohol consumption in women. , 1987, Scandinavian journal of gastroenterology.
[163] E. Zijlstra,et al. Post-kala-azar dermal leishmaniasis. , 2003, The Lancet. Infectious diseases.
[164] J. Krischer,et al. Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1. , 2005, Diabetes care.
[165] R. Ross. MALARIA in Greece. , 1906, Chronicle of the World Health Organization.
[166] G. Andrews. Randomised controlled trials in psychiatry: important but poorly accepted , 1999, BMJ.
[167] J. Galambos,et al. Natural history of alcoholic hepatitis. II. The long-term prognosis. , 1971, The American journal of gastroenterology.
[168] A. Tuulio-Henriksson,et al. Depressive symptoms in adolescence as predictors of early adulthood depressive disorders and maladjustment. , 2002, The American journal of psychiatry.
[169] K. Eriksson,et al. Prevention of Type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise The 6-year Malmö feasibility study , 1991, Diabetologia.
[170] M. Ingelman-Sundberg,et al. Ultrarapid metabolism of sparteine: frequency of alleles with duplicated CYP2D6 genes in a Danish population as determined by restriction fragment length polymorphism and long polymerase chain reaction. , 1998, Pharmacogenetics (London).
[171] A. Bener,et al. Obesity and low back pain. , 2003, Collegium antropologicum.
[172] G. Rutherford,et al. Changes in sexual behavior and risk of HIV transmission after antiretroviral therapy and prevention interventions in rural Uganda , 2006, AIDS.
[173] G. Andersson,et al. The epidemiology of spinal disorders , 1997 .
[174] S. Hammer,et al. Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. , 2000, JAMA.
[175] P. Olliaro,et al. Strategies for the prevention of antimalarial drug resistance: rationale for combination chemotherapy for malaria. , 1996, Parasitology today.
[176] N. Ait-Daoud,et al. Combining ondansetron and naltrexone effectively treats biologically predisposed alcoholics: from hypotheses to preliminary clinical evidence. , 2000, Alcoholism, clinical and experimental research.
[177] Mardge H. Cohen,et al. Depressive symptoms and AIDS-related mortality among a multisite cohort of HIV-positive women. , 2004, American journal of public health.
[178] E. Isometsä,et al. Depressive disorders in primary care: recurrent, chronic, and co-morbid , 2004, Psychological Medicine.
[179] A. Mitchell,et al. A cost-effectiveness approach to drug subsidy and pricing in Australia. , 2001, Health affairs.
[180] W. Fleischhacker,et al. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence , 1996, The Lancet.
[181] R. Morrison,et al. Effect of home-based neonatal care and management of sepsis on neonatal mortality: field trial in rural India , 1999, The Lancet.
[182] P. Desjeux. The increase in risk factors for leishmaniasis worldwide. , 2001, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[183] J. Cramer,et al. A systematic review of the associations between dose regimens and medication compliance. , 2001, Clinical therapeutics.
[184] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[185] J. Ioannidis,et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. , 2001, JAMA.
[186] F. Clavel,et al. HIV Drug Resistance , 2000, The New England journal of medicine.
[187] W. K. Lelbach,et al. CIRRHOSIS IN THE ALCOHOLIC AND ITS RELATION TO THE VOLUME OF ALCOHOL ABUSE , 1975, Annals of the New York Academy of Sciences.
[188] A. Alterman,et al. Naltrexone and alcohol dependence. Role of subject compliance. , 1997, Archives of general psychiatry.
[189] W. Katon,et al. Impact of antidepressant drug adherence on comorbid medication use and resource utilization. , 2005, Archives of internal medicine.
[190] Ramanan Laxminarayan,et al. Malaria: current status of control, diagnosis, treatment, and a proposed agenda for research and development. , 2002, The Lancet. Infectious diseases.
[191] John B Saunders,et al. CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. , 2002, Alcoholism, clinical and experimental research.
[192] Dean T. Jamison,et al. World development report 1993 : investing in health , 1993 .
[193] I. Ellis,et al. Best Practice No 176 , 2004, Journal of Clinical Pathology.
[194] S. Ahmedzai,et al. Overcoming the challenges to consumer involvement in cancer research , 2003, Health Expectations.
[195] R. Fuller,et al. Alcoholism treatment in the United States. An overview. , 1999 .
[196] S. Hurt,et al. Discontinuing or Switching Selective Serotonin-Reuptake Inhibitors , 2002, The Annals of pharmacotherapy.
[197] R. Macgregor,et al. Alcohol and infection. , 1997, Current clinical topics in infectious diseases.
[198] W. Klunk,et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.
[199] A. Beekman,et al. [Depression among older nursing home patients. A review]. , 2003, Tijdschrift voor gerontologie en geriatrie.
[200] Richard D Moore,et al. Characteristics, Diagnosis, and Treatment of Alcoholism in Elderly Patients , 1989, Journal of the American Geriatrics Society.
[201] A. Hofman,et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.
[202] B. Dilbaz,et al. Is rectal misoprostol really effective in the treatment of third stage of labor? A randomized controlled trial. , 2002, American journal of obstetrics and gynecology.
[203] S. Dooley,et al. Molecular Mechanisms of Alcohol-Induced Hepatic Fibrosis , 2006, Digestive Diseases.
[204] J. Best,et al. Rubella-specific serum and nasopharyngeal antibodies in volunteers with naturally acquired and vaccine-induced immunity after intranasal challenge. , 1980, The Journal of infectious diseases.
[205] C. Siegrist. Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. , 2003, Vaccine.
[206] A. Mitchell,et al. Prognosis of depression in old age compared to middle age: a systematic review of comparative studies. , 2005, The American journal of psychiatry.
[207] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[208] E. W. Olsen,et al. Dementia in affective disorde a case‐register study , 1999, Acta psychiatrica Scandinavica.
[209] Ron Z. Goetzel,et al. Health, Absence, Disability, and Presenteeism Cost Estimates of Certain Physical and Mental Health Conditions Affecting U.S. Employers , 2004, Journal of occupational and environmental medicine.
[210] N. Freemantle,et al. Pricing and reimbursement of pharmaceuticals in the Baltic States , 2001, The Lancet.
[211] M. Dewey,et al. Dementia, cognitive impairment and mortality in persons aged 65 and over living in the community: a systematic review of the literature , 2001, International journal of geriatric psychiatry.
[212] O. Gureje,et al. Risk of mortality for dementia in a developing country: the Yoruba in Nigeria , 2002, International journal of geriatric psychiatry.
[213] F. Scherer. The pharmaceutical industry--prices and progress. , 2004, The New England journal of medicine.
[214] N. Perrin,et al. Cost-effectiveness of an intervention to prevent depression in at-risk teens. , 2005, Archives of general psychiatry.
[215] J. Kastelein,et al. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials. , 2005, Journal of the American College of Cardiology.
[216] C. G. Victoria,et al. Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis , 2000, The Lancet.
[217] G. Elwyn,et al. Evolving the multiple roles of ‘patients’ in health‐care research: reflections after involvement in a trial of shared decision‐making , 2003, Health expectations : an international journal of public participation in health care and health policy.
[218] J. Caballería,et al. Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. , 1986, Journal of hepatology.
[219] Yiming Shao,et al. Enhanced: The Need for a Global HIV Vaccine Enterprise , 2003, Science.
[220] M. Hochberg,et al. Acetaminophen for osteoarthritis. , 2006, The Cochrane database of systematic reviews.
[221] Y. Israel,et al. Binding of acetaldehyde to a glutathione metabolite: mass spectrometric characterization of an acetaldehyde-cysteinylglycine conjugate. , 2003, Alcoholism, clinical and experimental research.
[222] R. Lipton,et al. Lost productive time and cost due to common pain conditions in the US workforce. , 2003, JAMA.
[223] A. Gibofsky. American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.
[224] M. Drummond,et al. A rational framework for decision making by the National Institute For Clinical Excellence (NICE) , 2002, The Lancet.
[225] T. Croghan,et al. The medicine cabinet: what's in it, why, and can we change the contents? , 2004, Health affairs.
[226] S. Glied,et al. Service system finance: implications for children with depression and manic depression , 2001, Biological Psychiatry.
[227] T. Sørensen,et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study , 1996, Hepatology.
[228] A. Ohlsson,et al. Inositol for respiratory distress syndrome in preterm infants. , 2012, The Cochrane database of systematic reviews.
[229] H. Hampel,et al. Advances in the development of biomarkers for Alzheimer’s disease: from CSF total tau and Aβ1–42 proteins to phosphorylated tau protein , 2003, Brain Research Bulletin.
[230] A. Hofman,et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.
[231] Richard Doll,et al. The causes of cancer. , 2001, Revue d'epidemiologie et de sante publique.
[232] G. Diggle. THALIDOMIDE: 40 YEARS ON , 2001, International journal of clinical practice.
[233] A. Penttilä,et al. Alcohol consumption and alcoholic liver disease: evidence of a threshold level of effects of ethanol. , 1993, Alcoholism, clinical and experimental research.
[234] W. Halperin,et al. Back pain prevalence in US industry and estimates of lost workdays. , 1999, American journal of public health.
[235] L. Markson,et al. Incidence and duration of side effects and those rated as bothersome with selective serotonin reuptake inhibitor treatment for depression: patient report versus physician estimate. , 2004, The Journal of clinical psychiatry.
[236] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[237] J. Dekker,et al. Combining psychotherapy and antidepressants in the treatment of depression. , 2001, Journal of affective disorders.
[238] B. Greenwood,et al. Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. , 1989, The American journal of tropical medicine and hygiene.
[239] J. Orbinski. Market Enticements Are Not Enough , 2001 .
[240] D M Eddy,et al. Selecting Technologies for Assessment , 1989, International Journal of Technology Assessment in Health Care.
[241] H. Jeffery,et al. Antibiotic regimens for suspected late onset sepsis in newborn infants. , 2005, The Cochrane database of systematic reviews.
[242] R L Andres,et al. Perinatal complications associated with maternal tobacco use. , 2000, Seminars in neonatology : SN.
[243] J. Margolick,et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. , 1995, The New England journal of medicine.
[244] A. Woolf,et al. Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.
[245] Y. Liaw,et al. Bacteremia in patients with cirrhosis of the liver. , 2008, Liver.
[246] Fernando Holguin,et al. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. , 2005, Chest.
[247] J. Sangiovanni,et al. Synergism of nutrition, infection, and immunity: an overview. , 1997, The American journal of clinical nutrition.
[248] T. Petty. The National Mucolytic Study. Results of a randomized, double-blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. , 1990, Chest.
[249] P. Aspden. Medical Innovation in the Changing Healthcare Marketplace: Conference Summary , 2002 .
[250] D. Tibboel,et al. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital. , 2001, Pediatrics.
[251] T. Kitagawa,et al. Annual incidence and clinical characteristics of type 2 diabetes in children as detected by urine glucose screening in the Tokyo metropolitan area. , 2005, Diabetes care.
[252] B. Ozkan,et al. Addition of orlistat to conventional treatment in adolescents with severe obesity , 2004, European Journal of Pediatrics.
[253] J. Scadding,et al. The James Lind Alliance: patients and clinicians should jointly identify their priorities for clinical trials , 2004, The Lancet.
[254] A. Diehl. ALCOHOL AND LIVER REGENERATION , 1998 .
[255] M. D. de Courten,et al. Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. , 2005, Diabetes care.
[256] Henry Chesbrough,et al. Open Innovation: The New Imperative for Creating and Profiting from Technology , 2003 .
[257] J. Boote,et al. Consumer involvement in health research : Fact or fiction? , 2002 .
[258] M Eccles,et al. Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme , 2001, Quality in health care : QHC.
[259] K. Krishnan,et al. Comparing the Effects of Antidepressants: Consensus Guidelines for Evaluating Quantitative Reviews of Antidepressant Efficacy , 2005, Neuropsychopharmacology.
[260] David Morganstein,et al. Cost of lost productive work time among US workers with depression. , 2003, JAMA.
[261] H. Jick,et al. Antidepressants and the risk of suicidal behaviors. , 2004, JAMA.
[262] Mark E Kunik,et al. Surprisingly high prevalence of anxiety and depression in chronic breathing disorders. , 2005, Chest.
[263] E. Christensen,et al. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. , 1995, Gut.
[264] D. Lau,et al. Long‐term pharmacotherapy for obesity and overweight , 2003 .
[265] K. Arrow,et al. Saving Lives, Buying Time , 2004 .
[266] N J Wald,et al. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials , 2003, BMJ : British Medical Journal.
[267] Rosemary Barber,et al. Principles and indicators of successful consumer involvement in NHS research: results of a Delphi study and subgroup analysis. , 2006, Health policy.
[268] Thomas P. Erlinger,et al. Smoking Cessation and Cardiovascular Disease Risk Factors: Results from the Third National Health and Nutrition Examination Survey , 2005, PLoS medicine.
[269] H. Cann,et al. A national DNA bank in The Gambia, West Africa, and genomic research in developing countries , 2004, Nature Genetics.
[270] D. McFarland,et al. Cost-effectiveness of oral cholera vaccine in a stable refugee population at risk for epidemic cholera and in a population with endemic cholera. , 1998, Bulletin of the World Health Organization.
[271] D. Foley,et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study , 2003, Neurobiology of Aging.
[272] A. Grizzle,et al. Understanding the costs and treatment of alcohol abuse and dependence , 2002 .
[273] Steff Lewis,et al. Forest plots: trying to see the wood and the trees , 2001, BMJ : British Medical Journal.
[274] W. van den Brink,et al. Response to tricyclic antidepressants: independent of gender? , 2004, The American journal of psychiatry.
[275] R. Riffenburgh,et al. Enhancing Intrinsic Cochlear Stress Defenses to Reduce Noise‐Induced Hearing Loss , 2002 .
[276] R. Kessler,et al. Depression and Work Productivity: The Comparative Costs of Treatment Versus Nontreatment , 2001, Journal of occupational and environmental medicine.
[277] G. Coatney,et al. A Naturally Acquired Quotidian-Type Malaria in Man Transferable to Monkeys , 1965, Science.
[278] Els Torreele,et al. Drug development for neglected diseases: a deficient market and a public-health policy failure , 2002, The Lancet.
[279] S. Goold. Allocating health care: cost-utility analysis, informed democratic decision making, or the veil of ignorance? , 1996, Journal of health politics, policy and law.
[280] M. McKeage,et al. Comparative Adverse Effect Profiles of Platinum Drugs , 1995, Drug safety.
[281] C. Day,et al. The management of alcoholic liver disease. , 2003, Journal of hepatology.
[282] David Sharp,et al. The Use of Intradiscal Steroid Therapy for Lumbar Spinal Discogenic Pain: A Randomized Controlled Trial , 2004, Spine.
[283] Eric J Topol,et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.
[284] Jürgen Unützer,et al. Cost-Effectiveness of a Program to Prevent Depression Relapse in Primary Care , 2002, Medical care.
[285] S. Ryder,et al. Investigation of liver and biliary disease , 2001, BMJ : British Medical Journal.
[286] J. Norbeck,et al. Naltrexone as an adjunctive treatment for older patients with alcohol dependence. , 1997, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[287] P. Saenger,et al. Presentation and 5-Year Follow-Up of Type 2 Diabetes mellitus in African-American and Caribbean-Hispanic Adolescents , 2003, Hormone Research in Paediatrics.
[288] K. Hall,et al. Alzheimer's disease, genes, and environment: the value of international studies. , 2003, Canadian journal of psychiatry. Revue canadienne de psychiatrie.
[289] D. Fergusson,et al. Mental health, educational, and social role outcomes of adolescents with depression. , 2002, Archives of general psychiatry.
[290] N. Moore,et al. Acamprosate appears to decrease alcohol intake in weaned alcoholics. , 1990, Alcohol and alcoholism.
[291] K. Freedland,et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.
[292] Peter Beresford,et al. Developing the theoretical basis for service user/survivor-led research and equal involvement in research , 2005, Epidemiologia e Psichiatria Sociale.
[293] T. Brown,et al. Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample. , 2001, Journal of abnormal psychology.
[294] W. Tooley,et al. Lung function in prematurely delivered rabbits treated with a synthetic surfactant. , 1987, The American review of respiratory disease.
[295] Basil Achilladelis,et al. The dynamics of technological innovation: The sector of antibacterial medicines , 1993 .
[296] J. Vestbo,et al. Socioeconomic status and chronic obstructive pulmonary disease , 1999, Thorax.
[297] W K Sieber,et al. Occupational exposure to noise and ototoxic organic solvents. , 1994, Archives of environmental health.
[298] P. Hammer. Differential Pricing of Essential AIDS Drugs: Markets, Politics and Public Health , 2002 .
[299] J. Hofmeyr,et al. Misoprostol in the treatment of postpartum haemorrhage in addition to routine management: a placebo randomised controlled trial , 2004, BJOG : an international journal of obstetrics and gynaecology.
[300] A Torén,et al. Tractor-driving hours and their relation to self-reported low-back and hip symptoms. , 2002, Applied ergonomics.
[301] V. Welch,et al. Glucosamine therapy for treating osteoarthritis. , 2005, The Cochrane database of systematic reviews.
[302] R. Aubert,et al. Evaluation of a depression health management program to improve outcomes in first or recurrent episode depression. , 2003, The American journal of managed care.
[303] E. Steliarova-Foucher,et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study , 2004, The Lancet.
[304] W. Mendoza,et al. Improving diarrhoea estimates. , 2002 .
[305] R. Nitrini,et al. Incidence of Dementia in a Community-Dwelling Brazilian Population , 2004, Alzheimer disease and associated disorders.
[306] L. Kessing,et al. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. , 2003, Journal of affective disorders.
[307] R. Grubb,et al. Guidelines for the Early Management of Patients With Ischemic Stroke: A Scientific Statement From the Stroke Council of the American Stroke Association , 2003, Stroke.
[308] M. von Korff,et al. The Course of Back Pain in Primary Care , 1996, Spine.
[309] R. Kessler,et al. Comorbidity of DSM–III–R Major Depressive Disorder in the General Population: Results from the US National Comorbidity Survey , 1996, British Journal of Psychiatry.
[310] B. Make,et al. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.
[311] P. Sager,et al. Effect of Ezetimibe Coadministered With Atorvastatin in 628 Patients With Primary Hypercholesterolemia: A Prospective, Randomized, Double-Blind Trial , 2003, Circulation.
[312] J. Unützer,et al. Adherence to Treatment for Geriatric Depression and Anxiety , 2003, CNS Spectrums.
[313] F. Smaill,et al. Antibiotic regimens for management of intraamniotic infection. , 2002, The Cochrane database of systematic reviews.
[314] P. Quennell. Getting their say, or getting their way? Has participation strengthened the patient "voice" in the National Institute for Clinical Excellence? , 2001, Journal of management in medicine.
[315] J. Ferlay,et al. Estimates of cancer incidence and mortality in Europe in 1995. , 2002, European journal of cancer.
[316] A. Dixon,et al. Primary care referrals for lumbar spine radiography: diagnostic yield and clinical guidelines. , 2002, The British journal of general practice : the journal of the Royal College of General Practitioners.
[317] L. Rybak,et al. Application of Antioxidants and Other Agents to Prevent Cisplatin Ototoxicity , 1999, The Laryngoscope.
[318] Mc Fiore,et al. Treating Tobacco Use and Dependence , 2000 .
[319] G. Andersson. Epidemiological features of chronic low-back pain , 1999, The Lancet.
[320] R. West,et al. Smoking cessation: evidence based recommendations for the healthcare system , 1999, BMJ.
[321] P. Wadhwa,et al. Stress and Preterm Birth: Neuroendocrine, Immune/Inflammatory, and Vascular Mechanisms , 2001, Maternal and Child Health Journal.
[322] G. Glikmann,et al. Subclinical measles infection in vaccinated seropositive individuals in arctic Greenland. , 1989, Vaccine.
[323] Shelly C. Lu,et al. Current Concepts in the Pathogenesis of Alcoholic Liver Injury , 2022 .
[324] B. N. Ong,et al. Involving users in low back pain research , 2003, Health expectations : an international journal of public participation in health care and health policy.
[325] J. Toolan. Depression in children and adolescents. , 1962, The American journal of orthopsychiatry.
[326] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[327] R. Suresh,et al. Ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia. , 2002, Journal of the American College of Cardiology.
[328] Organizatao Mundial DE Saude,et al. World Health Organization: Regional Office for Africa , 1954, Africa.
[329] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[330] G. Pransky,et al. The Association of Medical Conditions and Presenteeism , 2004, Journal of occupational and environmental medicine.
[331] F. Fleck. Eastern Europe and Russia face world's fastest growing HIV epidemic , 2004, BMJ : British Medical Journal.
[332] Shyam Sundar,et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. , 2002, The Lancet. Infectious diseases.
[333] Mark S. George,et al. Transcranial magnetic stimulation in neuropsychiatry , 2000 .
[334] R. Peto,et al. The natural history of chronic airflow obstruction. , 1977, British medical journal.
[335] B. Dubois,et al. Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization , 2003, Neurology.
[336] R. López-Vélez,et al. Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections , 2003, Annals of tropical medicine and parasitology.
[337] B. Grant. Prevalence and correlates of alcohol use and DSM-IV alcohol dependence in the United States: results of the National Longitudinal Alcohol Epidemiologic Survey. , 1997, Journal of studies on alcohol.
[338] N J Wald,et al. A strategy to reduce cardiovascular disease by more than 80% , 2003, BMJ : British Medical Journal.
[339] M. Law,et al. The underlying risk of death after myocardial infarction in the absence of treatment. , 2002, Archives of internal medicine.
[340] R. Nitrini,et al. Epidemiologic Survey of Dementia in a Community-Dwelling Brazilian Population , 2002, Alzheimer disease and associated disorders.
[341] A. Dyer,et al. Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. , 1993, Cardiology.
[342] A. Alterman,et al. Naltrexone in the treatment of alcohol dependence. , 1992, Archives of general psychiatry.
[343] C. Morel. Reaching maturity - 25 years of the TDR. , 2000, Parasitology today.
[344] K. Mendis,et al. The neglected burden of Plasmodium vivax malaria. , 2001, The American journal of tropical medicine and hygiene.
[345] A. Skene,et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. , 2005, The New England journal of medicine.
[346] W. Castle,et al. A follow-up of 93 newly diagnosed African diabetics for 6 years , 2004, Diabetologia.
[347] S. Loüet. Public–private partnerships boost research on neglected diseases , 2003, Nature Biotechnology.
[348] D. Higgins,et al. Housing and health: time again for public health action. , 2002, American journal of public health.
[349] T. Vesikari,et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.
[350] I. Wanless. Is cirrhosis reversible? , 2004 .
[351] N J Wald,et al. Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.
[352] A. Siitonen,et al. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine , 1991, The Lancet.
[353] S. Bellman,et al. The prevention of hearing loss. , 1983, International rehabilitation medicine.
[354] R. Carithers,et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. , 1989, Annals of internal medicine.
[355] L. Stead,et al. Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library , 2000, BMJ : British Medical Journal.
[356] J. Kenardy,et al. Psychological interventions for overweight or obesity. , 2014, The Cochrane database of systematic reviews.
[357] A. Silman,et al. Influence of previous pain experience on the episode incidence of low back pain: results from the South Manchester Back Pain Study , 1996, PAIN®.
[358] Lawrence A Leiter,et al. The Effect of Acarbose on Insulin Sensitivity in Subjects With Impaired Glucose Tolerance , 1996, Diabetes Care.
[359] E. Alpert,et al. Experimental mosquito-transmission of Plasmodium knowlesi to man and monkey. , 1968, The American journal of tropical medicine and hygiene.
[360] Z. Bhutta,et al. Hospital-acquired neonatal infections in developing countries , 2005, The Lancet.
[361] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.
[362] C. Jagger,et al. The prevalence of dementia in a total population: a comparison of two screening instruments. , 1991, Age and ageing.
[363] Melinda Moore,et al. Global urbanization and impact on health. , 2003, International journal of hygiene and environmental health.
[364] M. Austin,et al. Maternal stress and obstetric and infant outcomes: epidemiological findings and neuroendocrine mechanisms , 2000, The Australian & New Zealand journal of obstetrics & gynaecology.
[365] P. Rothwell,et al. External validity of randomised controlled trials: “To whom do the results of this trial apply?” , 2005, The Lancet.
[366] A. Bryceson,et al. Epidemic visceral leishmaniasis in Sudan: a randomized trial of aminosidine plus sodium stibogluconate versus sodium stibogluconate alone. , 1993, The Journal of infectious diseases.
[367] T. Petty,et al. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. , 1989, The American review of respiratory disease.
[368] P. Verbanck,et al. Efficacy and safety of acamprosate in the treatment of detoxified alcohol-dependent patients , 1997, British Journal of Psychiatry.
[369] Douglas K. Martin,et al. Priority setting in a hospital drug formulary: a qualitative case study and evaluation. , 2003, Health policy.
[370] A. McMichael,et al. The urban environment and health in a world of increasing globalization: issues for developing countries. , 2000, Bulletin of the World Health Organization.
[371] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[372] M. Crawford,et al. Systematic review of involving patients in the planning and development of health care , 2002, BMJ : British Medical Journal.
[373] Rod Hughes,et al. Patients and professionals as research partners: challenges, practicalities, and benefits. , 2006, Arthritis and rheumatism.
[374] Expert and non-expert knowledge in medical practice , 2000, Medicine, health care, and philosophy.
[375] V. Wiseman,et al. Involving the general public in priority setting: experiences from Australia. , 2003, Social science & medicine.
[376] D. Isacson,et al. Epidemiology of analgesic use: a gender perspective , 2002, European journal of anaesthesiology. Supplement.
[377] M. Zencir,et al. Cost of Alzheimer's disease in a developing country setting , 2005, International journal of geriatric psychiatry.
[378] C. Sempos,et al. Alcohol as a Risk Factor for Global Burden of Disease , 2003, European Addiction Research.
[379] D. B. Matthews,et al. The role of GABAergic neuroactive steroids in ethanol action, tolerance and dependence , 2001, Brain Research Reviews.
[380] C M O'Connor,et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. , 2001, Archives of internal medicine.
[381] G B Andersson,et al. The influence of lumbar disc height and cross-sectional area on the mechanical response of the disc to physiologic loading. , 1999, Spine.
[382] J. Pyne,et al. Cost-Effectiveness of Enhancing Primary Care Depression Management on an Ongoing Basis , 2005, The Annals of Family Medicine.
[383] J. Roussaux,et al. L'acamprosate diminue-t-il l'appétence pour l'alcool chez l'alcoolique sevé? , 1996 .
[384] D Elbourne,et al. Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey , 2001, BMJ : British Medical Journal.
[385] J Gabbay,et al. Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. , 2004, Health technology assessment.
[386] C. P. Thakur,et al. Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[387] S. Becker. New targets, new drugs, failed trials and the need for more information. , 2004, Positively aware : the monthly journal of the Test Positive Aware Network.
[388] Maurizio Bonati,et al. Survey of unlicensed and off label drug use in paediatric wards in European countries , 2000, BMJ : British Medical Journal.
[389] K. Katsouyanni,et al. Ethanol and breast cancer: An association that may be both confounded and causal , 1994, International journal of cancer.
[390] B. Lawlor,et al. Alcohol use disorders in elderly people–redefining an age old problem in old age , 2003, BMJ : British Medical Journal.
[391] M. Boldrin,et al. Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial. , 2005, JAMA.
[392] B. Lernfelt,et al. 15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.
[393] R. Stauber,et al. In vivo quantification of liver dialysis: comparison of albumin dialysis and fractionated plasma separation. , 2005, Journal of hepatology.
[394] M. Karsdal,et al. In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist? , 2005, Assay and drug development technologies.
[395] Luigi Orsenigo,et al. Global Competitiveness in Pharmaceuticals: A European Perspective , 2000 .
[396] J. T. Corwin,et al. Postembryonic production and aging of inner ear hair cells in sharks , 1981, The Journal of comparative neurology.
[397] S. Gapstur,et al. Alcohol and breast cancer: review of epidemiologic and experimental evidence and potential mechanisms. , 2001, JAMA.
[398] P. Raskin,et al. Treatment of hypertension in adults with diabetes. , 2003, Diabetes care.
[399] W. Tan,et al. Management of chronic obstructive pulmonary disease in Asia and Africa. , 2004, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[400] C. Muller,et al. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons , 1998, Journal of medical virology.
[401] R. Bullock. New drugs for Alzheimer's disease and other dementias , 2002, British Journal of Psychiatry.
[402] Philip Zeitler,et al. The global spread of type 2 diabetes mellitus in children and adolescents. , 2005, The Journal of pediatrics.
[403] Eric J Topol,et al. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.
[404] Gary J. Nabel,et al. The need for a global HIV vaccine enterprise. Policy forum. , 2003 .
[405] M. Woodward,et al. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack , 2001 .
[406] M. Frydenberg,et al. Mental disorders among internal medical inpatients: prevalence, detection, and treatment status. , 2001, Journal of psychosomatic research.
[407] Olga V. Demler,et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[408] A. Esposito. Community-acquired bacteremic pneumococcal pneumonia. Effect of age on manifestations and outcome. , 1984, Archives of internal medicine.
[409] G. Szabo. Consequences of alcohol consumption on host defence. , 1999, Alcohol and alcoholism.
[410] G. Justus Hofmeyr,et al. A randomised placebo controlled trial of oral misoprostol in the third stage of labour , 1998, British journal of obstetrics and gynaecology.
[411] B. Pécoul,et al. Access to essential drugs in poor countries: a lost battle? , 1999, JAMA.
[412] G. Dekker,et al. Calcium channel blockers for inhibiting preterm labour. , 2003, The Cochrane database of systematic reviews.
[413] N. Ford,et al. Neglected diseases of global importance. , 2001, JAMA.
[414] R. Motter,et al. Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease , 2000, Nature Medicine.
[415] H. Möller,et al. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. , 2000, Journal of affective disorders.
[416] Margaret T. Whitstock. Seeking evidence from medical research consumers as part of the medical research process could improve the uptake of research evidence. , 2003, Journal of evaluation in clinical practice.
[417] M. Arthur,et al. Sex differences in the metabolism of ethanol and acetaldehyde in normal subjects. , 1984, Clinical science.
[418] Douglas K. Martin,et al. Hospital priority setting with an appeals process: a qualitative case study and evaluation. , 2005, Health policy.
[419] Paul Dieppe,et al. Osteoarthritis: New Insights. Part 2: Treatment Approaches , 2000, Annals of Internal Medicine.
[420] S Holm,et al. The second phase of priority setting. Goodbye to the simple solutions: the second phase of priority setting in health care. , 1998, BMJ.
[421] J. Cutler,et al. Effect of Antihypertensive Drug Treatment on Cardiovascular Outcomes in Women and Men , 1997, Annals of Internal Medicine.
[422] R. Makuch,et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. , 2000, JAMA.
[423] Andrew W. Smith. The World Health Organisation and the prevention of deafness and hearing impairment caused by noise. , 1998, Noise & health.
[424] C. Brayne,et al. An Epidemiological Study of Dementia in a Rural Population of Elderly Women , 1989, British Journal of Psychiatry.
[425] J. Jordan,et al. Real-time polymerase chain reaction for detecting bacterial DNA directly from blood of neonates being evaluated for sepsis. , 2005, The Journal of molecular diagnostics : JMD.
[426] P. Lumbiganon,et al. Prophylactic antibiotic administration during second and third trimester in pregnancy for preventing infectious morbidity and mortality , 2002 .
[427] F. Ahern,et al. Gender Differences in NSAID Use among Older Adults with Osteoarthritis , 2003, The Annals of pharmacotherapy.
[428] D. Mannino. Chronic obstructive pulmonary disease: definition and epidemiology. , 2003, Respiratory care.
[429] G. Ostapowicz,et al. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection , 1998, Hepatology.
[430] R. Soll,et al. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. , 2001, The Cochrane database of systematic reviews.
[431] S. Wutzke,et al. Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting , 2002, The Medical journal of Australia.
[432] A. Brennan,et al. Modelling the long term cost effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK , 2005, Current medical research and opinion.
[433] G. Guyatt,et al. A controlled trial of ambroxol in chronic bronchitis. , 1987, Chest.
[434] D. Overstreet,et al. Combination pharmacotherapy: a mixture of small doses of naltrexone, fluoxetine, and a thyrotropin-releasing hormone analogue reduces alcohol intake in three strains of alcohol-preferring rats. , 2000, Alcohol and alcoholism.
[435] M. Santosham,et al. High incidence rates of invasive pneumococcal disease in the White Mountain Apache population. , 1992, Archives of internal medicine.
[436] P. Musgrove,et al. A critical review of 'a critical review': the methodology of the 1993 World Development Report, 'Investing in Health'. , 2000, Health policy and planning.
[437] Diggle Ge. Thalidomide: 40 years on. , 2001 .
[438] Candice L Schachter,et al. The Case for Integrating Grounded Theory and Participatory Action Research: Empowering Clients to Inform Professional Practice , 2005, Qualitative health research.
[439] Kari Kuulasmaa,et al. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. , 2004, Maturitas.
[440] Filip Smit,et al. Effects of reminiscence and life review on late‐life depression: a meta‐analysis , 2003, International journal of geriatric psychiatry.
[441] R. Bazell. Drug efficacy study: FDA yields on fixed combinations. , 1971, Science.
[442] M N Rossor,et al. The prevalence and causes of dementia in people under the age of 65 years , 2003, Journal of neurology, neurosurgery, and psychiatry.
[443] G. Uziel,et al. Inborn errors of metabolism in the Italian pediatric population: a national retrospective survey. , 2002, The Journal of pediatrics.
[444] T. Fliedner,et al. The critique of DALYs: a counter-reply. , 1997, Bulletin of the World Health Organization.
[445] L. Punnett,et al. Estimating the global burden of low back pain attributable to combined occupational exposures. , 2005, American journal of industrial medicine.
[446] M. Aubier,et al. A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease. , 1989, The New England journal of medicine.
[447] J. Li,et al. A 2‐year follow‐up study of cigarette smoking and risk of dementia , 2004, European journal of neurology.
[448] E. C. Moura,et al. Socioeconomic status and obesity in adult populations of developing countries: a review. , 2004, Bulletin of the World Health Organization.
[449] J. Bunders,et al. Patients’ priorities concerning health research: the case of asthma and COPD research in the Netherlands , 2005, Health expectations : an international journal of public participation in health care and health policy.
[450] Trey Sunderland,et al. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. , 2003, JAMA.
[451] C. Patterson,et al. Global Trends in Childhood Type 1 Diabetes , 2003 .
[452] Lex M. Bouter,et al. Conservative Treatment of Acute and Chronic Nonspecific Low Back Pain: A Systematic Review of Randomized Controlled Trials of the Most Common Interventions , 1997, Spine.
[453] O. Dodge,et al. Mycobacterial skin ulcers in Uganda. , 1961, Lancet.
[454] R. O'brien,et al. The need for new drugs against tuberculosis. Obstacles, opportunities, and next steps. , 2001, American journal of respiratory and critical care medicine.
[455] W. Kim,et al. Burden of liver disease in the United States: Summary of a workshop , 2002, Hepatology.
[456] S. Jan,et al. Vertical equity: weighting outcomes? or establishing procedures? , 1997, Health policy.
[457] R. Collins,et al. Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials , 2001, The Lancet.
[458] R Peto,et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. , 1991, BMJ.
[459] Alan Frazer,et al. Pharmacology of antidepressants. , 1997, Journal of clinical psychopharmacology.
[460] L. Kinlen. Mortality from smoking in developed countries 1950-2000 , 1996, British Journal of Cancer.
[461] M. Turgut,et al. The effects of calcium channel antagonist nimodipine on end-plate vascularity of the degenerated intervertebral disc in rats , 2003, Journal of Clinical Neuroscience.
[462] T. Brennan,et al. Incidence and types of preventable adverse events in elderly patients: population based review of medical records , 2000, BMJ : British Medical Journal.
[463] Deborah Pinchev,et al. Mining biomarkers in human sera using proteomic tools , 2004, Proteomics.
[464] J. Tuomilehto,et al. Worldwide increase in incidence of Type I diabetes – the analysis of the data on published incidence trends , 1999, Diabetologia.
[465] J. Horm,et al. Negative moods as correlates of smoking and heavier drinking: implications for health promotion. , 1993, Advance data.
[466] P. Olliaro,et al. A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[467] L. Bouter,et al. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials , 1997, Annals of the rheumatic diseases.
[468] L. Del Piccolo,et al. Which patients talk about stressful life events and social problems to the general practitioner? , 1998, Psychological Medicine.
[469] P. Bendtsen,et al. A 6-month controlled naltrexone study: combined effect with cognitive behavioral therapy in outpatient treatment of alcohol dependence. , 2003, Alcoholism, clinical and experimental research.
[470] M. Plummer,et al. International agency for research on cancer. , 2020, Archives of pathology.
[471] H C Hendrie,et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. , 1995, The American journal of psychiatry.
[472] S. Sachdeva,et al. Prevalence of Dementia in an Urban Indian Population , 2001, International Psychogeriatrics.
[473] R. Handsher,et al. Response to experimental challenge in persons immunized with different rubella vaccines. , 1978, The Journal of pediatrics.
[474] J. Moncrieff,et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. , 2000, Alcohol and alcoholism.
[475] A. Amos,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[476] K J Rothman,et al. Placebo mania , 1996, BMJ.
[477] Sean D Sullivan,et al. Methods to assess intended effects of drug treatment in observational studies are reviewed. , 2004, Journal of clinical epidemiology.
[478] E. R. Mcfadden,et al. Patterns of hospitalization in elderly patients with asthma and chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[479] K. Hawton,et al. Suicide in older people: mode of death, demographic factors, and medical contact before death , 2000, International journal of geriatric psychiatry.
[480] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[481] U. Reinhardt,et al. The world health report 2000 - Health systems: improving performance , 2000 .
[482] H. Whittle,et al. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa , 1999, The Lancet.
[483] M. Hill,et al. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. , 1997, Circulation.
[484] R. Mcnutt,et al. Acute Severe Low Back Pain: A Population-based Study of Prevalence and Care-seeking , 1996, Spine.
[485] I. Karacan,et al. Facet Angles in Lumbar Disc Herniation: Their Relation to Anthropometric Features , 2004, Spine.
[486] R. Nitrini,et al. Mortality from dementia in a community‐dwelling Brazilian population , 2005, International journal of geriatric psychiatry.
[487] K. Promodu,et al. An Epidemiological Study of Dementia in a Rural Community in Kerala, India , 1996, British Journal of Psychiatry.
[488] S. Friedman,et al. Liver fibrosis -- from bench to bedside. , 2003, Journal of hepatology.
[489] Patricia Dolan Mullen,et al. Treating tobacco use and dependence: clinical practice guideline , 2000 .
[490] R. Weinshilboum,et al. Pharmacogenomics: bench to bedside , 2004, Nature Reviews Drug Discovery.
[491] F. Turnbull. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials , 2003, The Lancet.
[492] Baker Rc,et al. Recent developments in alcoholism:immunological aspects. , 1993 .
[493] G. Suh,et al. A review of the epidemiological transition in dementia — cross‐national comparisons of the indices related to Alzheimer's disease and vascular dementia , 2001, Acta psychiatrica Scandinavica.
[494] Michael C. McDaniel,et al. Diets and cardiovascular disease: an evidence-based assessment. , 2005, Journal of the American College of Cardiology.
[495] P. Rochon,et al. Relation between randomized controlled trials published in leading general medical journals and the global burden of disease , 2004, Canadian Medical Association Journal.
[496] R. Wood‐Baker,et al. Influenza vaccine for patients with chronic obstructive pulmonary disease. , 2006, The Cochrane database of systematic reviews.
[497] A. Beck,et al. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. , 2006, Clinical psychology review.
[498] Guilbert Jj. The world health report 2002 - reducing risks, promoting healthy life. , 2003 .
[499] F. Chaloupka,et al. Tobacco Control in Developing Countries , 2001 .
[500] H. Kranzler,et al. Naltrexone vs. Nefazodone for Treatment of Alcohol Dependence: A Placebo-Controlled Trial , 2000, Neuropsychopharmacology.
[501] Jan P Vandenbroucke,et al. When are observational studies as credible as randomised trials? , 2004, The Lancet.
[502] Drug safety under the US Best Pharmaceuticals for Children Act , 2003 .
[503] John P. Moore,et al. New targets for inhibitors of HIV-1 replication , 2000, Nature Reviews Molecular Cell Biology.
[504] Stephen K. Smith,et al. Fetal Endocrine Signals and Preterm Labor , 2001, Neonatology.
[505] J. Vincent,et al. The cost of HIV/AIDS to businesses in southern Africa , 2004, AIDS.
[506] S. Sundar,et al. Advances in the treatment of leishmaniasis , 2002, Current opinion in infectious diseases.
[507] N. Walker,et al. Neonatal survival: a call for action , 2005, The Lancet.
[508] A. Medline,et al. Prognosis of alcoholic cirrhosis in the presence and absence of alcoholic hepatitis. , 1987, Gastroenterology.
[509] E. Leibing,et al. Diagnostic Groups and Depressed Mood as Predictors of 22-Month Mortality in Medical Inpatients , 1998, Psychosomatic medicine.
[510] Karen M Kuntz,et al. Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. , 2002, The New England journal of medicine.
[511] D. Prockop,et al. Rat Marrow Stromal Cells are More Sensitive to Plating Density and Expand More Rapidly from Single‐Cell‐Derived Colonies than Human Marrow Stromal Cells , 2001, Stem cells.
[512] T. Parsons,et al. Herbal therapy for treating osteoarthritis , 2000 .
[513] Fernando Costa,et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Ph , 2003, Circulation.
[514] I. Johnson. Alcohol problems in old age: a review of recent epidemiological research , 2000, International journal of geriatric psychiatry.
[515] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[516] L. Brion,et al. Diuretics for respiratory distress syndrome in preterm infants. , 2011, The Cochrane database of systematic reviews.
[517] C. Dewa,et al. Pattern of antidepressant use and duration of depression-related absence from work. , 2003, The British journal of psychiatry : the journal of mental science.
[518] P. Aaby,et al. Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial , 2005, BMJ : British Medical Journal.
[519] J. Pyne,et al. Cost-effectiveness of a primary care depression intervention , 2003, Journal of General Internal Medicine.
[520] Ronald C Kessler,et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? , 2003, The Journal of clinical psychiatry.
[521] P A West,et al. Economic evaluation of strategies for the control and management of influenza in Europe. , 2002, Vaccine.
[522] Jeffrey L. Smith,et al. The Effect of Improving Primary Care Depression Management on Employee Absenteeism and Productivity: A Randomized Trial , 2004, Medical care.
[523] F. Berrino,et al. Childhood cancer survival trends in Europe: a EUROCARE Working Group study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[524] C. Branch,et al. Posterior lumbar interbody fusion using recombinant human bone morphogenetic protein type 2 with cylindrical interbody cages. , 2004, The spine journal : official journal of the North American Spine Society.
[525] D. Bradley. The Commission on Health Research for Development. , 1989, The Journal of tropical medicine and hygiene.
[526] Timothy E. McAlindon,et al. Osteoarthritis: New Insights , 2002 .
[527] P. Passmore,et al. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease. , 2006, The Cochrane database of systematic reviews.
[528] J. F. Caron-Flinterman,et al. The experiential knowledge of patients: a new resource for biomedical research? , 2005, Social science & medicine.
[529] N. Bellamy,et al. Viscosupplementation for the treatment of osteoarthritis of the knee. , 2006, The Cochrane database of systematic reviews.
[530] A Hofman,et al. Diabetes mellitus and the risk of dementia , 1999, Neurology.
[531] R. Stawarz,et al. A possible common mechanism of action of antidepressant treatments , 1976, Naunyn-Schmiedeberg's Archives of Pharmacology.
[532] D. Sin,et al. The impact of chronic obstructive pulmonary disease on work loss in the United States. , 2002, American journal of respiratory and critical care medicine.
[533] T. Imperiale,et al. Do corticosteroids reduce mortality from alcoholic hepatitis? A meta-analysis of the randomized trials. , 1990, Annals of internal medicine.
[534] S. Holm,et al. Pathophysiology of disc degeneration. , 1993, Acta orthopaedica Scandinavica. Supplementum.
[535] M. Preboth. Clinical review of recent findings on the awareness, diagnosis and treatment of depression. , 2000, American family physician.
[536] M. H. Williams,et al. Bronchodilator response to oral aminophylline and terbutaline versus aerosol albuterol in patients with chronic obstructive pulmonary disease. , 1983, The American journal of medicine.
[537] Douglas K. Martin,et al. Fairness, accountability for reasonableness, and the views of priority setting decision-makers. , 2002, Health policy.
[538] G. Small. Recognition and treatment of depression in the elderly. , 1991, The Journal of clinical psychiatry.
[539] P. Small,et al. Partial Purification and Characterization of Biological Effects of a Lipid Toxin Produced byMycobacterium ulcerans , 1998, Infection and Immunity.
[540] J. Castilla,et al. Effectiveness of Highly Active Antiretroviral Therapy in Reducing Heterosexual Transmission of HIV , 2005, Journal of acquired immune deficiency syndromes.
[541] J. Manson,et al. Smoking Cessation and Time Course of Decreased Risks of Coronary Heart Disease in Middle-Aged Women , 1994 .
[542] P. Olliaro,et al. Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[543] S. Yusuf. Two decades of progress in preventing vascular disease , 2002, The Lancet.
[544] Catherine Sudlow,et al. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.
[545] John R. Geddes,et al. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis , 2003, The Lancet.
[546] C. Caso,et al. A double-blind, placebo-controlled study of naltrexone in the treatment of alcohol-dependence disorder: results from a multicenter clinical trial. , 2002, Alcoholism, clinical and experimental research.
[547] D. Selkoe,et al. Translating cell biology into therapeutic advances in Alzheimer's disease , 1999, Nature.
[548] L. Goodman,et al. THE PHARMACOLOGICAL BASIS OF THERAPEUTICS , 1966 .
[549] G. Koëter,et al. Cost‐Effectiveness of Lung Transplantation in Relation to Type of End‐Stage Pulmonary Disease , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[550] S. DeKosky,et al. Incidence of Alzheimer’s disease in a rural community in India , 2001, Neurology.
[551] R. Stern,et al. Severe adverse cutaneous reactions to drugs. , 1994, The New England journal of medicine.
[552] C. Ballantyne,et al. Combination therapy for combined dyslipidemia. , 2002, The American journal of cardiology.
[553] Ernst R Berndt,et al. Unemployment, job retention, and productivity loss among employees with depression. , 2004, Psychiatric services.
[554] L. Hughes,et al. The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. , 2003, Journal of the American Academy of Audiology.
[555] Solomon Nwaka,et al. Science & society: Virtual drug discovery and development for neglected diseases through public–private partnerships , 2003, Nature Reviews Drug Discovery.
[556] R. Calne,et al. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. , 1990, BMJ.
[557] Research and development costs for drugs , 2004, The Lancet.
[558] Yunus,et al. Field trial of oral cholera vaccines in Bangladesh: results from three-year follow-up , 1990, The Lancet.
[559] N. Peshu,et al. Signs of illness in Kenyan infants aged less than 60 days. , 2004, Bulletin of the World Health Organization.
[560] Beth E. Molnar,et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. , 1998, Addictive behaviors.
[561] N. Butte,et al. Comment on "Obesity and the Environment: Where Do We Go from Here?" , 2003, Science.
[562] D. Price,et al. The pharmacoepidemiology of COPD: Recent advances and methodological discussion , 2003, European Respiratory Journal.
[563] Claire Church,et al. How stable are medicines moved from original packs into compliance aids , 2006 .
[564] F. Weiss,et al. Behavioral Neurobiology of Alcohol Addiction: Recent Advances and Challenges , 2002, The Journal of Neuroscience.
[565] F Vinicor,et al. Diabetes--a common, growing, serious, costly, and potentially preventable public health problem. , 2000, Diabetes research and clinical practice.
[566] D. Mannino,et al. Changing the burden of COPD mortality , 2006, International journal of chronic obstructive pulmonary disease.